Open Access

Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin

  • Authors:
    • Liu-Mei Shou
    • Qiong-Yan Zhang
    • Wei Li
    • Xin Xie
    • Kai Chen
    • Lian Lian
    • Zhen-Yu Li
    • Fei-Ran Gong
    • Ke-Sheng Dai
    • Yi-Xiang Mao
    • Min Tao
  • View Affiliations

  • Published online on: July 8, 2013     https://doi.org/10.3892/or.2013.2601
  • Pages: 1059-1066
  • Copyright: © Shou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cancer metastasis is a highly coordinated and dynamic multistep process in which cancer cells interact with a variety of host cells. Morphological studies have documented the association of circulating tumor cells with host platelets, where a surface coating of platelets protects tumor cells from mechanical trauma and the immune system. Cantharidin is an active constituent of mylabris, a traditional Chinese medicine. Cantharidin and norcantharidin are potent protein phosphatase 2A (PP2A) inhibitors that exhibit in vitro and in vivo antitumor activity against several types of cancer, including breast cancer. We investigated whether cantharidin and norcantharidin could repress the ability of MCF-7 breast cancer cells to adhere to platelets. Using MTT, clone formation, apoptosis, adhesion and wound-healing assays, we found that cantharidin and norcantharidin induced apoptosis and repressed MCF-7 cell growth, adhesion and migration. Moreover, we developed a flow cytometry-based analysis of tumor cell adhesion to platelets. We proved that cantharidin and norcantharidin repressed MCF-7 cell adhesion to platelets through downregulation of α2 integrin, an adhesion molecule present on the surface of cancer cells. The repression of α2 integrin expression was found to be executed through the protein kinase C pathway, the activation of which could have been due to PP2A inhibition.
View Figures
View References

Related Articles

Journal Cover

September 2013
Volume 30 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shou L, Zhang Q, Li W, Xie X, Chen K, Lian L, Li Z, Gong F, Dai K, Mao Y, Mao Y, et al: Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncol Rep 30: 1059-1066, 2013
APA
Shou, L., Zhang, Q., Li, W., Xie, X., Chen, K., Lian, L. ... Tao, M. (2013). Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncology Reports, 30, 1059-1066. https://doi.org/10.3892/or.2013.2601
MLA
Shou, L., Zhang, Q., Li, W., Xie, X., Chen, K., Lian, L., Li, Z., Gong, F., Dai, K., Mao, Y., Tao, M."Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin". Oncology Reports 30.3 (2013): 1059-1066.
Chicago
Shou, L., Zhang, Q., Li, W., Xie, X., Chen, K., Lian, L., Li, Z., Gong, F., Dai, K., Mao, Y., Tao, M."Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin". Oncology Reports 30, no. 3 (2013): 1059-1066. https://doi.org/10.3892/or.2013.2601